0001640455-21-000037.txt : 20210212 0001640455-21-000037.hdr.sgml : 20210212 20210212081017 ACCESSION NUMBER: 0001640455-21-000037 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210210 FILED AS OF DATE: 20210212 DATE AS OF CHANGE: 20210212 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Salter-Cid Luisa CENTRAL INDEX KEY: 0001766404 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37998 FILM NUMBER: 21622920 MAIL ADDRESS: STREET 1: C/O GOSSAMER BIO, INC. STREET 2: 3013 SCIENCE PARK ROAD, SUITE 200 CITY: SAN DIEGO STATE: CA ZIP: 92121 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Jounce Therapeutics, Inc. CENTRAL INDEX KEY: 0001640455 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 454870634 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-259-3840 MAIL ADDRESS: STREET 1: 780 MEMORIAL DRIVE CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 wf-form4_161313540118759.xml FORM 4 X0306 4 2021-02-10 0 0001640455 Jounce Therapeutics, Inc. JNCE 0001766404 Salter-Cid Luisa C/O GOSSAMER BIO, INC. 3013 SCIENCE PARK ROAD, SUITE 200 SAN DIEGO CA 92121 1 0 0 0 Stock Option (Right to Buy) 12.36 2021-02-10 4 A 0 31400 0 A 2031-02-10 Common Stock 31400.0 31400 D The option was granted on February 10, 2021 and will vest in equal quarterly installments during the twelve quarters following the grant date, subject the to Reporting Person's continued service as a director. /s/ Caroline Gammill, Attorney-in-fact 2021-02-12